BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11769715)

  • 1. [Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells].
    He D; Zhang H
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):654-6. PubMed ID: 11769715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
    Yuan Z; Mei HD
    Hematol J; 2002; 3(4):201-5. PubMed ID: 12189566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inhibition of telomerase activity on cisplatin-induced apoptosis in K562 cells].
    He D; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):355-8. PubMed ID: 11877097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of human telomerase reverse transcriptase gene antisense oligodeoxynucleotide on telomerase activity in leukemia cells].
    He DM; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):523-6. PubMed ID: 12513713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antisense oligodeoxynucleotides of RNA component of human telomerase on cisplatin induced apoptosis in K562 cells].
    Xiao Y; Zhang H
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):144-7. PubMed ID: 12581964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
    Fei J; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Inhibition of Telomerase on Cisplatin-Induced Apoptosis in HL-60 Cells].
    He DM; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Sep; 9(3):215-219. PubMed ID: 12578592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of telomerase activity and induction of apoptosis in lung cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide].
    Wang X; Zhang Z; Xu Y; Chen S; Xiong W
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):175-8. PubMed ID: 11940318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.
    Baśkiewicz-Masiuk M; Machaliński B
    Eur J Haematol; 2004 Jun; 72(6):420-9. PubMed ID: 15128421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hTERT ASODN on the oncogenicity and the inductive apoptosis of HL-60 cells].
    Sun L; Wang F; Sun H; Le XP; Ge XF; Liu LX; Zhang QX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):386-9. PubMed ID: 17147228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells].
    He DM; Zhang H
    Ai Zheng; 2002 Oct; 21(10):1070-4. PubMed ID: 12508645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of c-myc antisense oligodeoxynucleotide on the telomerase activity and the induction of apoptosis in HL-60 cells].
    Sun L; Wang F; Sun H; Le XP; Liu LX; Liu YF; Wang F; Wang YH; Ma HY; Zhang QX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):605-9. PubMed ID: 16129043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knock-down of apollon gene by antisense oligodeoxynucleotide inhibits the proliferation of Lovo cells and enhances chemo-sensitivity].
    He JH; Zhang XY; Wu FY; Liao XL; Wang W; Jiang JW
    Yao Xue Xue Bao; 2011 Feb; 46(2):138-45. PubMed ID: 21542283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
    Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Bali P; Estrella V; Kumaraswamy S; Rao R; Rocha K; Herger B; Lee F; Richon V; Bhalla K
    Clin Cancer Res; 2006 Oct; 12(19):5869-78. PubMed ID: 17020995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.